Figure S2.
Transcriptional changes in NUAK2 mutant cells. (A) Q-PCR shows similar transcript level of Hippo components in both control and patient NPCs. (B) While the level of TAZ proteins was partly rescued in MG132-treated cells (lanes 4 and 6 vs. lanes 10 and 12), LATS2 remained lower in mutant cells. Results were confirmed in three independent Western blots. (C) Q-PCR showing transcriptional change in patient NPCs compared with control, especially in genes that are involved in actin polymerization, architecture, and dynamics. Transcription of YAP-targeted genes was significantly deregulated in patient cells compared with control. (D) Q-PCR showing transcriptional rescue of NUAK1 and CTGF in patient NS treated with BLEB and ROCK-I compared with control. Relative gene expression was normalized against the values for nontreated and treated control NS and set to 1. Q-PCR data represent the average ± SD of three technical replicates from two independent experiments. *, P < 0.05; **, P < 0.02; ***, P < 0.005; ns, not significant.